Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Completed · Phase 4 · Has a placebo group

Conditions studied: Type 2 Diabetes

In brief

A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.

Key facts

Study ID

NCT02288273

Run by

AstraZeneca

People needed

239

Starts

2014-12-01

Expected to finish

2015-08-01

Last updated by the study team

2017-01-27

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes mellitus (T2DM) treated with stable dose of metformin > or = to 1500mg/day as monotherapy for at least 8 weeks
• Hemoglobin A1c (HbA1c) 7% to 10% at screening
• Body mass index (BMI) < or = to 45 kg/m2

You may not qualify if…

• History of taking antihyperglycemic therapy other than metformin or metformin extended release (XR) during the 8 weeks prior to screening
• History of taking a dipeptidyl peptidase-4 (DPP-4) inhibitor or pramlintide during 12 weeks prior to screening
• History of potent, inhaled or intrapulmonary steroids 3 months prior to screening or during the study
• History of prescription or over the counter weight loss medication during 3 months prior to screening
• Previous exposure to exenatide or any glucagon-like peptide-1 (GLP-1) receptor agonist during 6 months prior to screening

Where it is running

• Research Site — Anaheim, California, United States
• Research Site — Chino, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — North Hollywood, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Spring Valley, California, United States
• Research Site — Tustin, California, United States
• Research Site — Walnut Creek, California, United States
• Research Site — Hollywood, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Port Orange, Florida, United States
• Research Site — Marietta, Georgia, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Edina, Minnesota, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Butte, Montana, United States
• Research Site — Las Vegas, Nevada, United States
• Research Site — Franklin, Ohio, United States
• Research Site — Marion, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Mt. Pleasant, South Carolina, United States
• Research Site — Rapid City, South Dakota, United States
• Research Site — Corpus Christi, Texas, United States
• Research Site — Houston, Texas, United States
• Research Site — Katy, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.